Suggested Topics within your search.
Showing 261 - 280 results of 1,073 for search 'Patient’s Medication Knowledge', query time: 0.14s Refine Results
  1. 261
  2. 262
  3. 263

    Gastric Dilation due to a Neuroleptic Agent in an Elderly Patient: A Case Report by V. Parent, L. Popitean, A. Loctin, A. Camus, P. Manckoundia

    Published 2014-01-01
    “…We describe here a case of gastric dilation related to treatment with a neuroleptic in an elderly man. To our knowledge, such a case has never been reported in the literature. …”
    Get full text
    Article
  4. 264
  5. 265

    Current applications and challenges in large language models for patient care: a systematic review by Felix Busch, Lena Hoffmann, Christopher Rueger, Elon HC van Dijk, Rawen Kader, Esteban Ortiz-Prado, Marcus R. Makowski, Luca Saba, Martin Hadamitzky, Jakob Nikolas Kather, Daniel Truhn, Renato Cuocolo, Lisa C. Adams, Keno K. Bressem

    Published 2025-01-01
    “…Abstract Background The introduction of large language models (LLMs) into clinical practice promises to improve patient education and empowerment, thereby personalizing medical care and broadening access to medical knowledge. …”
    Get full text
    Article
  6. 266
  7. 267

    When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review. by Leon Wreyford, Raj Gururajan, Xujuan Zhou

    Published 2023-01-01
    “…Thereafter, framework development for a future (cancer patient) online peer support intervention.<h4>Methods</h4>A Scoping Review was performed to identify peer reviewed studies that concern treatment / medication nonadherence in cancer patients-published between 2000 to 2021 (and partial 2022). …”
    Get full text
    Article
  8. 268

    Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia by Justine Chan, Paarth Shah, Guillermo Moguel-Cobos

    Published 2019-01-01
    “…The mechanisms behind this adverse effect are not clear; however, her symptoms began after nilotinib was introduced, decreased with dose reduction, stopped with its cessation, and re-emerged when the medication was restarted. To our knowledge, this is the first reported patient with neurologic symptoms secondary to nilotinib use.…”
    Get full text
    Article
  9. 269

    A Smart Chatbot for Interactive Management in Beta Thalassemia Patients by Alma Mohammed Alturaiki, Haneen Reda Banjar, Ahmed Salleh Barefah, Salwa Abdulrahman Alnajjar, Salwa Hindawi

    Published 2022-01-01
    “…Consequently, many patients do not receive adequate information about the required assessments, as indicated by evidence-based medical guidelines. …”
    Get full text
    Article
  10. 270
  11. 271
  12. 272

    The Impact of Hyperoxia on Outcome of Patients Treated with Noninvasive Respiratory Support by Seyhan Pala Cifci, Yasemin Urcan Tapan, Bengu Turemis Erkul, Yusuf Savran, Bilgin Comert

    Published 2020-01-01
    “…One hundred and eighty-seven patients who met inclusion criteria, treated in Dokuz Eylul University Medical Intensive Care Unit between January 1, 2016, and October 31, 2018, were examined retrospectively. …”
    Get full text
    Article
  13. 273
  14. 274

    IPV Screening and Readiness to Respond to IPV in Ob-Gyn Settings: A Patient-Physician Study by Katherine M. Jones, Laura H. Taouk, Neko M. Castleberry, Michele M. Carter, Jay Schulkin

    Published 2018-01-01
    “…Workplace encouragement of IPV response was associated with training, screening, detection, preparation/knowledge, response practices, and resources. Thirty-one percent of patients indicated their ob-gyn had asked about possible IPV experiences during their medical visit. …”
    Get full text
    Article
  15. 275
  16. 276

    A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient by Alastair David Bezzina, Isaac Bertuello

    Published 2022-01-01
    “…The patient had presented to a routine medical follow-up and complained of a few weeks’ history of dyspnoea and tachycardia after minimal exertion followed by acute bilateral blurring of vision. …”
    Get full text
    Article
  17. 277
  18. 278

    Delirium management and current practice among Intensive Care Units Doctors, Khartoum [version 3; peer review: 1 approved, 2 approved with reservations] by Mudawi Mohammed Ahmed Abdallah, Sheema Hamid Seidna Hamid, Hana Eltayeb Salih Elamin, Ghada Omer Hamad Abd El-Raheem

    Published 2024-11-01
    “…Our doctors prescribed antipsychotics for the treatment of both forms of delirium, and almost half of them did not stop the medications on ICU discharge. Medication reconciliation and contact with the next in-charge of the patients are important.…”
    Get full text
    Article
  19. 279

    Factors associated with delays in seeking tuberculosis treatment among patients at Muhima district hospital, Rwanda by Mercy Nwankwo, Chinenye, Yasmin Omar, Umubyeyi

    Published 2022
    “…About 57% (28) of the respondents have poor knowledge of TB transmission. Similarly, about 51% (25) were the results on the perception of taking anti- TB medication, while median time interval from onset of symptoms and initiation of treatments was 45 days, average 71 days between 15 -180 days. …”
    Get full text
    Article
  20. 280

    Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator... by Jason M Glanz, Ingrid A Binswanger, Shane R Mueller, Komal J Narwaney, Nicole M Wagner, Stanley Xu, Courtney R Kraus, Kris Wain, Sheila Botts

    Published 2024-04-01
    “…The objective of this study was to determine if a targeted, digital health intervention changed patient risk behaviour, increased naloxone uptake and increased knowledge about opioid overdose prevention and naloxone.Methods We conducted a pragmatic randomised clinical trial among patients prescribed LTOT in a healthcare delivery system in Colorado. …”
    Get full text
    Article